Addiction Medicine Journal Club: Effect of Initiation of Medications for Opioid Use Disorder On Hospitalization Outcomes for Endocarditis and Osteomyelitis - Audio_Episode 6

INSTRUCTIONS - Start Here

Addiction is a disease that can be treated, and these audios will help you stay up to date with the latest research that you can use in your addiction medicine practice. In each episode of Addiction Medicine Journal Club, we discuss articles or studies related to addiction.

In this episode of Addiction Medicine Journal Club, we discuss an article titled “Effect of initiation of medications for opioid use disorder on hospitalization outcomes for endocarditis and osteomyelitis in a large private hospital system in the United States, 2014–18.”

It is a retrospective study looking at how the initiation of methadone and buprenorphine in patients with opioid use disorder hospitalized with endocarditis or osteomyelitis affects their duration of antibiotic treatment, early discharges, and readmissions rates.

Article citation: Jo Y, Nosal R, Vittori A, et al. Effect of initiation of medications for opioid use disorder on hospitalization outcomes for endocarditis and osteomyelitis in a large private hospital system in the United States, 2014–18. Addiction. 2021;116:2127–2134.

In our introduction we again revisit the controversy surrounding dental problems with buprenorphine and discuss an ASAM letter to the FDA regarding the warning.

If you want your comments about this article included in a future episode, leave them in your CME quiz, email us at [email protected], talk to us on Twitter @AddicionMedJC, or even record a comment using the voice memo app on your phone and email it to us. Thank you for being part of the conversation.

Credits
Host: Sonya Del Tredici, MD
Host: John Keenan, MD
Music: Benjamin Kennedy
Audio Production: Angela Ohlfest
CME Coordinator: georgeanna ledgerwood, MLIS/LMT
Sponsor: WellSpan Health

References for staying up to date on addiction research and policy:
https://www.evidencealerts.com/" Evidence Alerts
https://www.asam.org/publications-resources/the-asam-weekly ASAM Weekly
https://www.asam.org/advocacy/advocacy-in-action/the-asam-advocate" ASAM Advocate

**PLEASE NOTE: to claim MOC credit for this activity, after completion of the activity and evaluation, you will need to go to the evaluation page and click "Claim MOC."**

1. Discuss the study design, results, and limitations of the research reviewed and how to apply those results to current practice
2. Describe how the conclusions of the featured article affect current treatment of opioid use disorder in osteomyelitis and endocarditis
3. Describe the main results from the article regarding treatment of patients with opioid use disorder with buprenorphine or methadone when they are hospitalized for endocarditis of osteomyelitis

AMA PRA Category 1 Credits™ (0.50 hours), ABA MOCA Part 2 (0.50 hours), ABA MOCA Patient Safety (0.50 hours), ABOS MOC (0.50 hours), ABPath MOC Part II (0.50 hours), ABS CC SAM (0.50 hours), ABTS CC Part II (0.50 hours), ABTS Patient Safety (0.50 hours), Act 124 Opioid Continuing Education Qualified (0.50 hours), Act 13 Patient Safety/Risk Management Credits (0.50 hours), Non-Physician Attendance (0.50 hours)

Sunday, May 1, 2022, 1:00 AM - Thursday, May 1, 2025, 12:00 AM

Accreditation Statement: WellSpan Health is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians. 

Credit Designation: WellSpan Health designates this Enduring Material activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All faculty participating in continuing medical education programs sponsored by WellSpan Health are expected to disclosure to the program audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s).

Mitigation of Relevant Financial Relationships

WellSpan Health CME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.